Thalidomide Survivors Compensation Act of 2025
Sponsor

Full profile: /officials/V000133
Source: Congress.gov · FEC
Cosponsors (0)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-10-28
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Veterans' AffairsReferred To · 2025-10-28
- House Committee on Financial ServicesReferred To · 2025-10-28
- House Committee on Transportation and InfrastructureReferred To · 2025-10-28
- House Committee on Education and WorkforceReferred To · 2025-10-28
- House Committee on AgricultureReferred To · 2025-10-28
- House Committee on Energy and CommerceReferred To · 2025-10-28
- House Committee on the JudiciaryReferred To · 2025-10-28
- House Committee on Natural ResourcesReferred To · 2025-10-28
- House Committee on Ways and MeansReferred To · 2025-10-28
Plain-English Summary
Thalidomide Survivors Compensation Act of 2025 This bill establishes a program to compensate individuals injured by exposure to thalidomide. (Thalidomide is a medication previously used to treat nausea in pregnant women until the 1960s when it was discovered thalidomide causes severe, life-threatening birth defects. Thalidomide is still used to treat multiple myeloma and leprosy, with federal restrictions to prevent use during pregnancy.) Specifically, individuals seeking compensation may submit a petition to the Department of Health and Human Services (HHS) by May 31, 2034, with documentation from a health professional of an injury caused by exposure to thalidomide. HHS must provide $150,000 to individuals showing such injury, as determined by an expert panel. Eligible individuals must have been a U.S. citizen or permanent resident at the time of exposure and at the time the petition was submitted. HHS may pay individuals compensated under the program additional compensation for ongoing medical or other needs as funds allow after HHS' annual review of the program, as required by the bill. Compensation provided under the bill may not be considered when calculating income or assets under any federal program designed to provide assistance exclusively to low-income individuals (i.e., means-tested programs), including certain programs and funds specified in the bill. Compensation under the program is also excluded from gross income for federal tax purposes.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR9207Military Pension Protection ActReferred to Committee · 2026-06-08
- HR8194Agent Orange Service Medal ActReferred to Committee · 2026-04-02
- HR7991STOP RGGI ActReferred to Committee · 2026-03-18
- HR7931IDA Act of 2026Referred to Committee · 2026-03-12